Dow Down0.92% Nasdaq Down0.83%

TrovaGene, Inc. (TROV)

4.24 Down 0.21(4.72%) 3:59PM EDT
ProfileGet Profile for:
TrovaGene, Inc.
11055 Flintkote Avenue
Suite B
San Diego, CA 92121
United States - Map
Phone: 858-952-7570

Index Membership:N/A
Full Time Employees:25

Business Summary 

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. Its technology is used in the detection and monitoring of diseases in various medical disciplines, primarily the management of cancer treatment. The company’s proprietary urine-based molecular diagnostic tests are used to detect cell-free DNA and RNA originating from normal and diseased cell death that can be isolated and detected from urine. Its technology is applied in various testing, such as tumor mutation detection and monitoring, infectious disease monitoring, transplantation monitoring, and prenatal genetic diagnostics. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on TrovaGene, Inc.

Key Executives 
Dr. Antonius P. Schuh Ph.D., 50
Chief Exec. Officer and Director
Mr. Stephen L. Zaniboni MBA, CPA, 56
Chief Financial Officer and Principal Accounting Officer
Dr. Mark Erlander Ph.D.,
Chief Scientific Officer
Dr. Gary S. Jacob Ph.D., 67
Sec., Independent Director, Member of Audit Committee and Member of Compensation Committee
Mr. B. Keith Mccormick MBA,
VP of Sales & Marketing
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders